Hormone therapy increases breast cancer risk in transgender women, study finds

Transgender women who take hormone therapy have a higher risk of breast cancer than the general male population but a lower risk than the general female population, a study has reported.

The paper, published in The BMJ,1 also found that the time between exposure to hormone treatment and breast cancer diagnosis was relatively short in transgender women (median 18 years), suggesting a “rapid” development of breast …